PM Equity Partner
Profile, fund size and portfolio
PM Equity Partner is the corporate venture arm of Philip Morris International, a consumer goods and retail company. It was founded in 2016 and is based in Lausanne, Switzerland. It invests at the Series A stage. Sectors it names: biotech and life sciences, industrial technology and robotics, consumer and retail, healthcare and digital health.
Every figure links to its source
Snapshot
Data behind this graphic
| Item | Value |
|---|---|
| Stage range | Series A to Series A |
| Sectors | Biotech and life sciences, Industrial technology and robotics, Consumer and retail, Healthcare and digital health, Climate and energy |
| Geography | Global |
| Offices | Lausanne, Switzerland |
Sources: S1 PM Equity Partner: About us; S3 PMI press release: additional USD 200 million to PM Equity Partner (28 Oct 2021).
Data behind this graphic
| Item | Companies | Share |
|---|---|---|
| Exited | 4 | 57.1% |
| Active | 3 | 42.9% |
Status as the firm tags it
Sources: S2 PM Equity Partner: Backed by PMEP.
Data behind this graphic
| Measure | Value | Unit | Kind | Source |
|---|---|---|---|---|
| Headline size | USD 350M | Fund size | Stated by the firm or its parent | S1 |
| Companies backed | 16 | companies | Stated by the firm | S2 |
| Companies on the firm's portfolio page | 7 | companies | Counted from the firm's own list | S2 |
Sources: S1 PM Equity Partner: About us; S2 PM Equity Partner: Backed by PMEP.
Where it invests and who leads it
LeadersS1
- Dean HaworthInvestment Director and Head of PMEPFind on LinkedInFirm page
- Cristina Oka DobrowolskiInvestment DirectorFind on LinkedInFirm page
- Bruno ChamielecVice President InvestmentFind on LinkedInFirm page
- Anna CotterellSenior Investment ManagerFind on LinkedInFirm page
- David SaviozSenior Investment ManagerFind on LinkedInFirm page
Key facts
| Fact | Value | Status | Source |
|---|---|---|---|
| Parent company | Philip Morris International (NYSE: PM) | Single source | S3 |
| Parent industry | Consumer goods and retail | Single source | S3 |
| Founded | 2016 | Single source | S3 |
| Headquarters | Lausanne, Switzerland | Single source | S1 |
| Status | Active | Single source | S2 |
| Capital source | Parent company only | Single source | S3 |
| Headline size | USD 350M (Fund size) | Single source | S1 |
| Companies backed | 16 | Single source | S2 |
| Stages | Series A | Single source | S1 |
About Philip Morris International
For founders
Fund vehicles
History
Portfolio
The firm's portfolio page lists 7 companies: 4 exited, 3 active.S2
The firm also states 16 companies backed. The page list and the stated total measure different things.S2
| Tag | Companies | Share |
|---|---|---|
| Exited | 4 | 57.1% |
| Active | 3 | 42.9% |
Every company on the PM Equity Partner list
7 companies, as listed on the firm's own website: 4 exited, 3 active.S2 Read the firm's list.
Exited 4
- Biognosys
- Comet Bio
- Softhale
- Treatech
Active 3
- Azuri
- Moodify
- Neuro
Official pages
Read the firm's own pages for current information.
- Website www.pmequitypartner.com
Sources
Disclaimer and corrections
Not affiliated. This page is not affiliated with, endorsed by or sponsored by PM Equity Partner or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.
Spotted a mistake? Report a correction.